BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3019470)

  • 1. Chronic dietary lithium induces increased levels of myo-inositol-1-phosphatase activity in rat cerebral cortex homogenates.
    Renshaw PF; Joseph NE; Leigh JS
    Brain Res; 1986 Aug; 380(2):401-4. PubMed ID: 3019470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.
    Hallcher LM; Sherman WR
    J Biol Chem; 1980 Nov; 255(22):10896-901. PubMed ID: 6253491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids.
    Pettegrew JW; Panchalingam K; McClure RJ; Gershon S; Muenz LR; Levine J
    Bipolar Disord; 2001 Aug; 3(4):189-201. PubMed ID: 11552958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat.
    Sherman WR; Leavitt AL; Honchar MP; Hallcher LM; Phillips BE
    J Neurochem; 1981 Jun; 36(6):1947-51. PubMed ID: 6264039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lithium on phosphoinositide metabolism in vivo.
    Sherman WR; Gish BG; Honchar MP; Munsell LY
    Fed Proc; 1986 Oct; 45(11):2639-46. PubMed ID: 3019784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronically administered lithium alters neither myo-inositol monophosphatase activity nor phosphoinositide levels in rat brain.
    Honchar MP; Ackermann KE; Sherman WR
    J Neurochem; 1989 Aug; 53(2):590-4. PubMed ID: 2545823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of systemically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis.
    Sherman WR; Munsell LY; Gish BG; Honchar MP
    J Neurochem; 1985 Mar; 44(3):798-807. PubMed ID: 2983019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
    Parthasarathy LK; Seelan RS; Wilson MA; Vadnal RE; Parthasarathy RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential uptake of lithium isotopes by rat cerebral cortex and its effect on inositol phosphate metabolism.
    Sherman WR; Munsell LY; Wong YH
    J Neurochem; 1984 Mar; 42(3):880-2. PubMed ID: 6319612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain.
    Tricklebank MD; Singh L; Jackson A; Oles RJ
    Brain Res; 1991 Aug; 558(1):145-8. PubMed ID: 1657311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of lithium isotopes on the myo-inositol 1-phosphatase reaction in rat brain, liver, and testes.
    Parthasarathy R; Parthasarathy L; Ramesh TG; Devi CS; Vadnal RE
    Life Sci; 1992; 50(19):1445-50. PubMed ID: 1315412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that inositol 1-phosphate in brain of lithium-treated rats results mainly from phosphatidylinositol metabolism.
    Ackermann KE; Gish BG; Honchar MP; Sherman WR
    Biochem J; 1987 Mar; 242(2):517-24. PubMed ID: 3036092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R; Parthasarathy R
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dephosphorylation of myo-inositol 1,4,5-trisphosphate and myo-inositol 1,3,4-triphosphate.
    Shears SB; Storey DJ; Morris AJ; Cubitt AB; Parry JB; Michell RH; Kirk CJ
    Biochem J; 1987 Mar; 242(2):393-402. PubMed ID: 3036088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that phosphoinositide metabolism in rat cerebral cortex stimulated by pilocarpine, physostigmine, and pargyline in vivo is not changed by chronic lithium treatment.
    Honchar MP; Vogler GP; Gish BG; Sherman WR
    J Neurochem; 1990 Nov; 55(5):1521-5. PubMed ID: 2170579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lithium treatment inhibits basal and agonist-stimulated responses in rat cerebral cortex and GH3 pituitary cells.
    Varney MA; Godfrey PP; Drummond AH; Watson SP
    Mol Pharmacol; 1992 Oct; 42(4):671-8. PubMed ID: 1435742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy.
    Patel S; Yenush L; Rodríguez PL; Serrano R; Blundell TL
    J Mol Biol; 2002 Jan; 315(4):677-85. PubMed ID: 11812139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dephosphorylation of 1D-myo-inositol 1,4-bisphosphate in rat liver.
    Morris AJ; Storey DJ; Downes CP; Michell RH
    Biochem J; 1988 Sep; 254(3):655-60. PubMed ID: 2848493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
    Faraci WS; Zorn SH; Bakker AV; Jackson E; Pratt K
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.
    Pachter JA
    Mol Pharmacol; 1991 Jul; 40(1):107-11. PubMed ID: 1649963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.